PRILIGY LICENSE AGREEMENT This License Agreement (hereinafter referred to as the “Agreement”) made and entered into as of this May 14, 2012. by and between GENUPRO, INC. a corporation organized under the laws of the State of North Carolina having its...Pharmacovigilance Agreement • August 7th, 2012 • Furiex Pharmaceuticals, Inc. • Pharmaceutical preparations • England
Contract Type FiledAugust 7th, 2012 Company Industry JurisdictionWHEREAS, LICENSOR and its Affiliates own or have licensed certain intellectual property related to the Product (as defined herein below),
Portions of this exhibit marked [*] are requested to be treated confidentially. CONFIDENTIAL LICENSE AND ASSET TRANSFER AGREEMENT BY AND BETWEEN ALZA CORPORATION AND JANSSEN PHARMACEUTICA, NV AND FURIEX PHARMACEUTICALS, INC., AND GENUPRO, INC. (A...License and Asset Transfer Agreement • August 7th, 2012 • Furiex Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledAugust 7th, 2012 Company Industry JurisdictionThis License and Asset Transfer Agreement (the “Agreement”), by and between ALZA CORPORATION, a company incorporated in the State of Delaware and having offices at 700 Eubanks Drive, Vacaville, California 95688 and JANSSEN PHARMACEUTICA NV, a corporation organised under the laws of the Kingdom of Belgium and having its principal place of business at Turnhoutseweg 30, B-2340 Beerse, Belgium (“JANSSEN”) (collectively “ALZA”), and FURIEX PHARMACEUTICALS, INC., a company incorporated in the State of Delaware and having its registered office at 3900 Paramount Parkway, Suite 150, Morrisville, NC 27560 (“FURIEX”) and GenuPro, Inc. (“GENUPRO”), a wholly-owned subsidiary of FURIEX organized under the laws of the State of North Carolina and having its registered office at 3900 Paramount Parkway, Suite 150, Morrisville, NC 27560, is entered into as of the date of signature by the last Party to sign below and is effective upon the satisfaction of the conditions set forth in Section 2 below (the “E